US20250064919A1
University of Texas System
1 . A SARS-CoV-2 vaccine comprising an engineered Human parainfluenza virus (HPIV) encoding a SARS-CoV-2 spike protein (S protein) in a transcriptional cassette. 2 . The vaccine of claim 1 , wherein the Human parainfluenza virus is a Human parainfluenza virus type 3 (HIPV3). 3 . The vaccine of claim 1